Search Results
Jun 05, 2026, 08:55 ET NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
5thInvestors are reacting to the May jobs report after the DOW climbed to a record close on Thursday.AstraZeneca (NYSE: AZN) is celebrating its February transfer to the NYSE, the largest transfer by market capitalization in the NYSE's 234-year history.NYSE
More news about: New York Stock Exchange
Apr 29, 2026, 19:00 ET Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca
pioneering next-generation targeted protein degradation approaches for cancer and other serious diseases, today announced that AstraZeneca (LSE/STO/NYSE: AZN) has exercised its option under the companies' previously announced
More news about: PineTree Therapeutics
Mar 03, 2026, 17:31 ET Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Chronic Kidney Disease CompaniesAstraZeneca (LON: AZN), Boehringer Ingelheim, Mineralys Therapeutics (NASDAQ: MLYS), ProKidney (NASDAQ: PROK), Disc Medicine (NASDAQ: IRON), Regeneron Pharmaceuticals (NASDAQ:
More news about: DelveInsight Business Research, LLP
Mar 02, 2026, 17:31 ET Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
to increase over the forecast period.Leading biliary tract cancer companies, such as TransThera Sciences (HKG: 2617), AstraZeneca (LON: AZN), J-Pharma, OHARA Pharmaceutical (TYO: 5218), Compass Therapeutics (NASDAQ: CMPX), Merck (NYSE: MRK), Eisai (TYO: 4523), Seagen (NASDAQ: SGEN), Pfizer
More news about: DelveInsight Business Research, LLP
Feb 11, 2026, 17:31 ET EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
Diamond Therapeutics (NASDAQ: BDTX), Lantern Pharma (NASDAQ: LTRN), Dizal Pharmaceutical (SHA: 688192), Daiichi Sankyo (TYO: 4568), AstraZeneca (LON: AZN), Jiangsu Hansoh Pharmaceutical, Boehringer Ingelheim, Pfizer (NYSE: PFE), Johnson & Johnson Innovative Medicine (NYSE: JNJ), Yuhan Corporation (KRX:
More news about: DelveInsight Business Research, LLP
Feb 10, 2026, 08:30 ET Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
Johnson (NYSE: JNJ), AbbVie Inc. (NYSE: ABBV), Takeda Pharmaceutical Company Limited (NYSE: TAK) and AstraZeneca PLC (NYSE: AZN).
More news about: Market News Updates
Oct 09, 2025, 06:00 ET Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to test the ability of Turbine's platform to rationalize antibody-drug conjugate (ADC) discovery by predicting response mechanisms, informing ADC positioning,
More news about: Turbine
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the
More news about: SOPHiA GENETICS
Sep 22, 2025, 08:00 ET SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the
More news about: SOPHiA GENETICS
Sep 17, 2025, 08:30 ET Advancing Cancer Research Brings New Hope for Patients Worldwide
innovators — including Iovance Biotherapeutics Inc. (NASDAQ: IOVA), Merck & Co. Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Bristol-Myers Squibb Co. (NYSE: BMY) — that are driving advances in these challenging therapeutic areas.
More news about: NetworkNewsWire
Aug 13, 2025, 07:00 ET The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact
AstraZenecaAstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology,
More news about: Healthcare Businesswomen's Association
Aug 05, 2025, 06:40 ET SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy, value, and real-world
More news about: SOPHiA GENETICS
Aug 05, 2025, 06:40 ET SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy, value, and real-world
More news about: SOPHiA GENETICS